{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:25:30Z","timestamp":1785522330132,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Preliminary Work Project of Provincial Capital Construction of Guizhou Provincial Development and Reform Commission","award":["2020-181-131"],"award-info":[{"award-number":["2020-181-131"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13608-9","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:43:24Z","timestamp":1779954204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delayed diagnosis of patients with rifampicin-resistant tuberculosis and its associated factors in a high tuberculosis endemic area Guizhou, China"],"prefix":"10.1186","volume":"26","author":[{"given":"Wen","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"13608_CR1","unstructured":"Chinese Center for Disease Control and Prevention, Centre for Tuberculosis Prevention and Control. Technical guidelines for tuberculosis prevention and control in China. Beijing: People\u2019s Health Press; 2021."},{"key":"13608_CR2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2147\/RMHP.S400667","volume":"16","author":"Y Wang","year":"2023","unstructured":"Wang Y, Huang Z, Chen H, Yuan Y, McNeil EB, Lu X, et al. The Association Between Household Financial Burden and Patient Mobility and Their Impact on Loss to Follow-Up Among Multidrug-Resistant Tuberculosis Patients in Guizhou, China. Risk Manag Healthc Policy. 2023;16:909\u201319.","journal-title":"Risk Manag Healthc Policy"},{"key":"13608_CR3","volume-title":"Global tuberculosis report 2024","author":"WHO","year":"2025","unstructured":"WHO. Global tuberculosis report 2024. Geneva: World Health Organization; 2025."},{"issue":"8","key":"13608_CR4","first-page":"1048","volume":"37","author":"YY He","year":"2022","unstructured":"He YY, Ruan YZ, Chen P, Chen HJ, Su W, Li RZ, et al. Detection of rifampicin-resistant tuberculosis in Guizhou during the 13th Five-Year Plan period. Disease Surveillance. 2022;37(8):1048\u201352.","journal-title":"Disease Surveillance"},{"key":"13608_CR5","volume-title":"Diagnostic and treatment delay in tuberculosis","author":"WHO","year":"2006","unstructured":"WHO. Diagnostic and treatment delay in tuberculosis. Geneva: World Health Organization; 2006."},{"issue":"1","key":"13608_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12879-024-09036-2","volume":"24","author":"TY Akalu","year":"2024","unstructured":"Akalu TY, Clements A, Gebreyohannes EA, Xu Z, Bai L, Alene KA. Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China. BMC Infect Dis. 2024;24(1):159.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"13608_CR7","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/adc.88.12.1106","volume":"88","author":"HS Schaaf","year":"2003","unstructured":"Schaaf HS, Shean K, Donald PR. Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome. Arch Dis Child. 2003;88(12):1106\u201311.","journal-title":"Arch Dis Child"},{"issue":"1","key":"13608_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12879-017-2200-8","volume":"17","author":"J Iruedo","year":"2017","unstructured":"Iruedo J, O\u2019Mahony D, Mabunda S, Wright G, Cawe B. The effect of the Xpert MTB\/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa\u2019s Eastern Cape Province. BMC Infect Dis. 2017;17(1):91.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"13608_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5588\/pha.16.0075","volume":"6","author":"HD Shewade","year":"2016","unstructured":"Shewade HD, Govindarajan S, Thekkur P, Palanivel C, Muthaiah M, Kumar AM, et al. MDR-TB in Puducherry, India: reduction in attrition and turnaround time in the diagnosis and treatment pathway. Public Health Action. 2016;6(4):242\u20136.","journal-title":"Public Health Action"},{"issue":"4","key":"13608_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jegh.2017.07.001","volume":"7","author":"HD Shewade","year":"2017","unstructured":"Shewade HD, Nair D, Klinton JS, Parmar M, Lavanya J, Murali L, et al. Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India. J Epidemiol Glob Health. 2017;7(4):227\u201333.","journal-title":"J Epidemiol Glob Health"},{"issue":"4","key":"13608_CR11","doi-asserted-by":"publisher","first-page":"e214943","DOI":"10.1371\/journal.pone.0214943","volume":"14","author":"C Xu","year":"2019","unstructured":"Xu C, Li R, Shewade HD, Jeyashree K, Ruan Y, Zhang C, et al. Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors. PLoS ONE. 2019;14(4):e214943.","journal-title":"PLoS ONE"},{"issue":"1","key":"13608_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40249-020-00719-x","volume":"9","author":"XB Zheng","year":"2020","unstructured":"Zheng XB, Diwan VK, Zhao Q, Hu Y, Bruchfeld J, Jiang WL, et al. Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study. Infect Dis Poverty. 2020;9(1):97.","journal-title":"Infect Dis Poverty"},{"key":"13608_CR13","doi-asserted-by":"crossref","unstructured":"Noman M, Islam S, Aktar S, Parray AA, Amando DG, Karki J, et al. Healthcare seeking behavior and delays in case of drug-resistant tuberculosis patients in Bangladesh: findings from a cross-sectional survey. PLoS Glob Public Health. 2024;4(1):e1903.","DOI":"10.1371\/journal.pgph.0001903"},{"issue":"8","key":"13608_CR14","first-page":"627","volume":"2","author":"TW Steen","year":"1998","unstructured":"Steen TW, Mazonde GN. Pulmonary tuberculosis in Kweneng District, Botswana: delays in diagnosis in 212 smear-positive patients. Int J Tuberc Lung Dis. 1998;2(8):627\u201334.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"18","key":"13608_CR15","first-page":"5","volume":"48","author":"DF Li","year":"2021","unstructured":"Li DF, Yu YQ, Lu QQ, Yuan ZK. Analysis of treatment status of drug-resistant tuberculosis and cost of anti-tuberculosis drugs in Jiangxi Province. Mod Prev Med. 2021;48(18):5.","journal-title":"Mod Prev Med"},{"key":"13608_CR16","doi-asserted-by":"crossref","unstructured":"Lu J, Xu Y, Li Z, Chen X, Lin H, Zhao Q. Diagnosis and treatment pathway of MDR\/RR-TB in Taizhou, Zhejiang Province, China. Trop Med Infect Dis. 2023;8(2).","DOI":"10.3390\/tropicalmed8020079"},{"issue":"1","key":"13608_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1186\/s12913-018-3715-4","volume":"18","author":"YM Htun","year":"2018","unstructured":"Htun YM, Khaing T, Yin Y, Myint Z, Aung ST, Hlaing TM, et al. Delay in diagnosis and treatment among adult multidrug resistant tuberculosis patients in Yangon Regional Tuberculosis Center, Myanmar: a cross-sectional study. BMC Health Serv Res. 2018;18(1):878.","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"13608_CR18","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/cid\/ciy1105","volume":"69","author":"A Bulabula","year":"2019","unstructured":"Bulabula A, Nelson JA, Musafiri EM, Machekano R, Sam-Agudu NA, Diacon AH, et al. Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB\/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012\u20132017: A Retrospective Province-Wide Cohort Study. Clin Infect Dis. 2019;69(8):1278\u201387.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"13608_CR19","first-page":"3410","volume":"51","author":"DF Wang","year":"2024","unstructured":"Wang DF, Guo XL, Ma XX, Wang Y, Zhou JJ, Zhou J, et al. Status and influencing factors of treatment delay of rifampicin resistant tuberculosis patients, Guizhou,2016\u20132022. Mod Prev Med. 2024;51(18):3410\u20135.","journal-title":"Mod Prev Med"},{"key":"13608_CR20","volume-title":"WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis","author":"WHO","year":"2025","unstructured":"WHO. WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis. Geneva: World Health Organization; 2025."},{"issue":"7","key":"13608_CR21","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cmi.2020.12.031","volume":"27","author":"L Zhang","year":"2021","unstructured":"Zhang L, Weng TP, Wang HY, Sun F, Liu YY, Lin K, et al. Patient pathway analysis of tuberculosis diagnostic delay: a multicentre retrospective cohort study in China. Clin Microbiol Infect. 2021;27(7):1000\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"13608_CR22","doi-asserted-by":"crossref","unstructured":"Oga OC, Tseja AA, Sen P, Mac SM, Agbaje A, Menzies D, et al. Factors influencing diagnosis and treatment initiation for multidrug-resistant\/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review. BMJ Glob Health. 2020;5(7).","DOI":"10.1136\/bmjgh-2019-002280"},{"issue":"09","key":"13608_CR23","first-page":"926","volume":"42","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zhou L, Liu EY, Zhao YL, Li T, Chen MT, et al. A survey on the diagnostic ability of tuberculosis in the county-level medical institutions in China. Chin J Antituberculosis. 2020;42(09):926\u201330.","journal-title":"Chin J Antituberculosis"},{"key":"13608_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1741-7015-11-156","volume":"11","author":"Y Li","year":"2013","unstructured":"Li Y, Ehiri J, Tang S, Li D, Bian Y, Lin H, et al. Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med. 2013;11:156.","journal-title":"BMC Med"},{"issue":"1","key":"13608_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1186\/s12879-016-1995-z","volume":"16","author":"SB Gebreegziabher","year":"2016","unstructured":"Gebreegziabher SB, Bjune GA, Yimer SA. Patients\u2019 and health system\u2019s delays in the diagnosis and treatment of new pulmonary tuberculosis patients in West Gojjam Zone, Northwest Ethiopia: a cross-sectional study. BMC Infect Dis. 2016;16(1):673.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13608_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40249-020-00665-8","volume":"9","author":"A Teo","year":"2020","unstructured":"Teo A, Ork C, Eng S, Sok N, Tuot S, Hsu LY, et al. Determinants of delayed diagnosis and treatment of tuberculosis in Cambodia: a mixed-methods study. Infect Dis Poverty. 2020;9(1):49.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"13608_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12931-021-01841-6","volume":"22","author":"A Teo","year":"2021","unstructured":"Teo A, Singh SR, Prem K, Hsu LY, Yi S. Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: a mixed-methods systematic review and meta-analysis. Respir Res. 2021;22(1):251.","journal-title":"Respir Res"},{"key":"13608_CR28","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2147\/RMHP.S367998","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Luo L, Gui M, Liu L, Lin Y, Deng G, et al. Duration and Determinants of Delayed Diagnosis with Tuberculosis in Shenzhen, China: A Cross-Sectional Study. Risk Manag Healthc Policy. 2022;15:1473\u201381.","journal-title":"Risk Manag Healthc Policy"},{"issue":"1","key":"13608_CR29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1186\/s12879-018-3609-4","volume":"18","author":"AM Peri","year":"2018","unstructured":"Peri AM, Bernasconi DP, Galizzi N, Matteelli A, Codecasa L, Giorgio V, et al. Determinants of patient and health care services delays for tuberculosis diagnosis in Italy: a cross-sectional observational study. BMC Infect Dis. 2018;18(1):690.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"13608_CR30","first-page":"1403","volume":"14","author":"EL Maciel","year":"2010","unstructured":"Maciel EL, Golub JE, Peres RL, Hadad DJ, Favero JL, Molino LP, et al. Delay in diagnosis of pulmonary tuberculosis at a primary health clinic in Vitoria, Brazil. Int J Tuberc Lung Dis. 2010;14(11):1403\u201310.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13608_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2458-9-53","volume":"9","author":"MM Mesfin","year":"2009","unstructured":"Mesfin MM, Newell JN, Walley JD, Gessessew A, Madeley RJ. Delayed consultation among pulmonary tuberculosis patients: a cross-sectional study of 10 DOTS districts of Ethiopia. BMC Public Health. 2009;9:53.","journal-title":"BMC Public Health"},{"issue":"1","key":"13608_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4236\/jtr.2022.101004","volume":"10","author":"D Soumare","year":"2022","unstructured":"Soumare D, Baya B, Ouattara K, Kanoute T, Sy CM, Karembe S, et al. Identifying Risk Factors for Pulmonary Tuberculosis Diagnosis Delays in Mali a West-African Endemic Country. J Tuberc Res. 2022;10(1):45\u201359.","journal-title":"J Tuberc Res"},{"issue":"4","key":"13608_CR33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/imj.16223","volume":"54","author":"N Vigneswaran","year":"2024","unstructured":"Vigneswaran N, Parnis R, Lowbridge C, Townsend D, Ralph AP. Factors leading to diagnostic delay in tuberculosis in the tropical north of Australia. Intern Med J. 2024;54(4):582\u20137.","journal-title":"Intern Med J"},{"issue":"3","key":"13608_CR34","doi-asserted-by":"publisher","first-page":"e152287","DOI":"10.1371\/journal.pone.0152287","volume":"11","author":"N Mistry","year":"2016","unstructured":"Mistry N, Rangan S, Dholakia Y, Lobo E, Shah S, Patil A. Durations and Delays in Care Seeking, Diagnosis and Treatment Initiation in Uncomplicated Pulmonary Tuberculosis Patients in Mumbai, India. PLoS ONE. 2016;11(3):e152287.","journal-title":"PLoS ONE"},{"issue":"18","key":"13608_CR35","first-page":"3372","volume":"45","author":"FF Chen","year":"2018","unstructured":"Chen FF, Feng XL, Chen W. Investigation and analysis on knowledge rate of tuberculosis control in Guizhou province. Mod Prev Med. 2018;45(18):3372\u20135.","journal-title":"Mod Prev Med"},{"issue":"11","key":"13608_CR36","first-page":"1283","volume":"26","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen HJ, Lu XL, et al. Three types of treatment delay and influencing factors among Multidrug-resistant Tuberculosis patients in Guizhou Province, 2014\u20132020. Chin J Disease Control Prev. 2022;26(11):1283\u20139.","journal-title":"Chin J Disease Control Prev"},{"key":"13608_CR37","unstructured":"Ma XX, Rao W, Guo SQ, Chen P, Zhou J, Luo L, et al. Epidemiological characteristics and spatial clustering analysis of rifampicin-resistant pulmonary tuberculosis in Guizhou Province, 2017\u20132023. China Trop Med. 2025:1\u20138."},{"issue":"11","key":"13608_CR38","doi-asserted-by":"publisher","first-page":"e280578","DOI":"10.1371\/journal.pone.0280578","volume":"18","author":"Y Yang","year":"2023","unstructured":"Yang Y, Liu L, Yang X, Li L, Lu K, Chen J, et al. Changing trend analysis on early detection of rifampicin resistant tuberculosis patients in southwestern area of China, 2016\u20132020. PLoS ONE. 2023;18(11):e280578.","journal-title":"PLoS ONE"},{"issue":"18","key":"13608_CR39","first-page":"3415","volume":"48","author":"XX Ma","year":"2021","unstructured":"Ma XX, Zhou J, Tian J, Zhou JJ, Guo XL, Chen HJ, et al. Spatial and temporal distribution characteristics of pulmonary tuberculosis in Guizhou Province from 2015 to 2020. Mod Prev Med. 2021;48(18):3415\u201320.","journal-title":"Mod Prev Med"},{"issue":"11","key":"13608_CR40","first-page":"1281","volume":"28","author":"LY Zhuo","year":"2024","unstructured":"Zhuo LY, Cao H, Du KN, Zhang Y, Zhang Y, Lei LJ. Delay on care-seeking and related influencing factors among tuberculosis patients in Zigong,2013\u20132022. Chin J Disease Control Prev. 2024;28(11):1281\u20136.","journal-title":"Chin J Disease Control Prev"},{"issue":"1","key":"13608_CR41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12879-021-05929-8","volume":"21","author":"W Xiao","year":"2021","unstructured":"Xiao W, Huang D, Li S, Zhou S, Wei X, Chen B, et al. Delayed diagnosis of tuberculosis in patients with diabetes mellitus co-morbidity and its associated factors in Zhejiang Province, China. BMC Infect Dis. 2021;21(1):272.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"13608_CR42","doi-asserted-by":"publisher","first-page":"e1004409","DOI":"10.1371\/journal.pmed.1004409","volume":"21","author":"TA Jhaveri","year":"2024","unstructured":"Jhaveri TA, Jhaveri D, Galivanche A, Lubeck SM, Voehler D, Chung M, et al. Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies. PLoS Med. 2024;21(5):e1004409.","journal-title":"PLoS Med"},{"issue":"1","key":"13608_CR43","first-page":"1","volume":"44","author":"HH Tola","year":"2015","unstructured":"Tola HH, Tol A, Shojaeizadeh D, Garmaroudi G. Tuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic Review. Iran J Public Health. 2015;44(1):1\u201311.","journal-title":"Iran J Public Health"},{"issue":"12","key":"13608_CR44","first-page":"2282","volume":"57","author":"J Hu","year":"2022","unstructured":"Hu J, Liu YY, Ye JQ. Epidemiological Characteristics of Drug-Resistant Tuberculosis and Influencing Factors of Multidrug-Resistant Tuberculosis in Jiangxi Province. Jiangxi Med J. 2022;57(12):2282\u20135.","journal-title":"Jiangxi Med J"},{"issue":"09","key":"13608_CR45","first-page":"1368","volume":"41","author":"ZB Zhang","year":"2020","unstructured":"Zhang ZB, Wang GY, Wang XJ, Lu ZQ, Ren X, Wu G, et al. Delay in treatment and influencing factors of student tuberculosis patients in Wuhan from 2011 to 2018. Chin J School Health. 2020;41(09):1368\u201371.","journal-title":"Chin J School Health"},{"issue":"12","key":"13608_CR46","first-page":"1275","volume":"43","author":"YZ Ruan","year":"2021","unstructured":"Ruan YZ, Su W, Jiang JW, Li RZ. The effect of case finding of pulmonary tuberculosis and rifampicin resistance tuberculosis with GeneXpert MTB\/RIF test in economic undeveloped areas. Chin J Antituberculosis. 2021;43(12):1275\u20139.","journal-title":"Chin J Antituberculosis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13608-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13608-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13608-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:14:05Z","timestamp":1785518045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13608-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13608"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13608-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki. The research used fully anonymized, pre-existing surveillance data extracted from the Guizhou Provincial Tuberculosis Information Management System. All personal identifiers (including names, national identification numbers, and addresses) had been removed by the Guizhou Center for Disease Control and Prevention before data were provided to the research team. According to national regulations governing the use of anonymized public health surveillance data in China, this type of secondary analysis does not require ethical review or informed consent. The Ethics Committee of the Guizhou Center for Disease Control and Prevention reviewed the study protocol and waived the requirement for ethical approval and informed consent, as the research involved no contact with participants and posed no risk to individuals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Third party material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Dual publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1398"}}